ASIA-PACIFIC DRUG DISCOVERY MARKET 2019-2028

Lifesciences | Diagnostic & Biotechnology

ASIA-PACIFIC DRUG DISCOVERY MARKET 2019-2028

Market by Drug Type, Technology, Service, End-user, and Country | Forecast 2019-2028

Request Free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

The Asia-Pacific drug discovery market is expected to reach a significant growth with a CAGR of 6.88% in terms of revenue over the forecasting years 2019-2028.


Report scope can be customized per your requirements. Request For Customization

The drug discovery market in Asia-Pacific comprises the following countries:

•           China

•           India

•           Japan

•           South Korea

•           Australia & New Zealand

•           ASEAN countries

•           Rest of APAC

Companies in Japan are focusing on drug discovery processes, and have been witnessing numerous advancements in terms of drug development. This is propelling the market in a forward direction. A report from the Japanese government states that the companies operating in the country have developed a revolutionary system, the Peptide Discovery Platform System (PPDS). This system helps create millions of peptides manually. It can also be used to extract these peptides for developing a new drug. The primary reason for creating such a system is that non-standard peptides can develop a drug having fewer no side-effects. Thus, the importance of the PPDS system has increased in Japan, and the country is taking a step ahead for drug discovery purposes. This is expected to benefit the Japanese drug discovery market significantly in the coming years.

Pharmaceutical companies based in China are steadily moving from manufacturing low-cost generics to the process of new drug discovery itself. The nation has established a large-scale chemical library for R&D purposes for new drugs. This has led to the discovery of a series of lead compounds by integrating data obtained from different technology-based strategies. India has been contributing to the growth of the drug discovery market by initiating in-house drug discovery projects across the country. The Indian government has been taking numerous initiatives, such as the Pharma Vision 2020, to make India one of the leading destinations in the world for end-to-end drug manufacturing.

Eli Lilly and Company is a drug manufacturing company that is engaged in developing, manufacturing, and making its products in two segments, namely human pharmaceutical products and animal health products. The company provides its products in various areas of specialty medicine like cardiovascular disease, diabetes, neuroscience, endocrine diseases, urology, and oncology. The company has a notable presence in the Asia-Pacific. It has entered into partnerships with many companies in India and China.


Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1.    ASIA-PACIFIC DRUG DISCOVERY MARKET - SUMMARY

2.    INDUSTRY OUTLOOK

2.1. MARKET DEFINITION

2.2. PORTER'S FIVE FORCES MODEL

2.2.1.   THREATS OF NEW ENTRANTS

2.2.2.   THREAT OF SUBSTITUTE PRODUCTS

2.2.3.   BARGAINING POWER OF BUYERS

2.2.4.   BARGAINING POWER OF SUPPLIERS

2.2.5.   COMPETITIVE RIVALRY

2.3. COVID-19 AND ITS IMPACT ON DRUG DISCOVERY MARKET

2.4. PESTLE OUTLOOK

2.5. REGULATORY FRAMEWORK

2.6. VALUE CHAIN OUTLOOK

2.7. MARKET ATTRACTIVENESS INDEX

2.8. KEY INSIGHT

2.9. MARKET DRIVERS

2.9.1.   GROWING AGED POPULATION

2.9.2.   TECHNOLOGICAL ADVANCEMENTS

2.9.3.   RISE IN HEALTHCARE EXPENDITURE

2.9.4.   SURGE IN LIFESTYLE-ORIENTED DISEASES

2.10.   MARKET RESTRAINTS

2.10.1.   DELAY IN PRODUCT LAUNCHES

2.10.2. RESTRICTED GROWTH RATE DUE TO GENERIC DRUGS

2.11.    MARKET OPPORTUNITIES

2.11.1.   SIGNIFICANT INVESTMENT BY HEALTHCARE INDUSTRIES IN IMPROVING BIG DATA ANALYTICAL CAPABILITIES

2.11.2.   RISING DEMAND FOR SPECIALTY MEDICINES

2.12.   MARKET CHALLENGES

2.12.1.   POOR REIMBURSEMENTS POLICIES IN EMERGING NATIONS

2.12.2.  STRINGENT GOVERNMENT REGULATIONS

3.    DRUG DISCOVERY MARKET OUTLOOK - BY DRUG TYPE

3.1. SMALL MOLECULE DRUG

3.2. BIOLOGIC DRUG

4.    DRUG DISCOVERY MARKET OUTLOOK - BY TECHNOLOGY

4.1. HIGH THROUGHPUT SCREENING

4.2. BIOCHIPS

4.3. BIOINFORMATICS

4.4. PHARMACOGENOMICS AND PHARMACOGENETICS

4.5. COMBINATORIAL CHEMISTRY

4.6. NANOTECHNOLOGY

4.7. SPECTROSCOPY

4.8. METABOLOMICS

4.9. OTHER TECHNOLOGIES

5.    DRUG DISCOVERY MARKET OUTLOOK - BY SERVICE

5.1. DRUG METABOLISM AND PHARMACOKINETICS (DMPK) SERVICES

5.2. CHEMICAL SERVICES

5.3. BIOLOGICAL SERVICES

5.4. OTHER PHARMACEUTICAL SERVICES

6.    DRUG DISCOVERY MARKET OUTLOOK - BY END-USER

6.1. RESEARCH INSTITUTES

6.2. PHARMACEUTICAL COMPANIES

6.3. CONTRACT RESEARCH ORGANIZATIONS (CROS)

6.4. OTHER END-USERS

7.    DRUG DISCOVERY MARKET – ASIA-PACIFIC

7.1. COUNTRY ANALYSIS

7.1.1.   CHINA

7.1.2.   INDIA

7.1.3.   JAPAN

7.1.4.   SOUTH KOREA

7.1.5.   AUSTRALIA & NEW ZEALAND

7.1.6.   ASEAN COUNTRIES

7.1.7.   REST OF ASIA-PACIFIC

8.    COMPANY PROFILES

8.1. 3M COMPANY

8.2. ABBOTT LABORATORIES INC

8.3. AGILENT TECHNOLOGIES INC

8.4. ANTARES PHARMA INC

8.5. ASTRAZENECA PLC

8.6. BAYER AG

8.7. BECTON DICKINSON & COMPANY (BD)

8.8. BOEHRINGER INGELHEIM

8.9. ELI LILY AND COMPANY

8.10.   F HOFFMANN-LA ROCHE LTD

8.11.   GLAXOSMITHKLINE LLC

8.12.   JOHNSON & JOHNSON

8.13.   MERCK & CO INC

8.14.   NOVARTIS

8.15.   PFIZER INC

8.16.    SANOFI

9.    RESEARCH METHODOLOGY & SCOPE

9.1. RESEARCH SCOPE & DELIVERABLES

9.1.1.   OBJECTIVES OF STUDY

9.1.2.   SCOPE OF STUDY

9.2. SOURCES OF DATA

9.2.1.   PRIMARY DATA SOURCES

9.2.2.   SECONDARY DATA SOURCES

9.3. RESEARCH METHODOLOGY

9.3.1.   EVALUATION OF PROPOSED MARKET

9.3.2.   IDENTIFICATION OF DATA SOURCES

9.3.3.   ASSESSMENT OF MARKET DETERMINANTS

9.3.4.   DATA COLLECTION

9.3.5.   DATA VALIDATION & ANALYSIS

List of table

TABLE 1        ASIA-PACIFIC DRUG DISCOVERY MARKET, BY COUNTRY, 2019-2028 ($ MILLION)

TABLE 2        ASIA-PACIFIC DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019-2028 ($ MILLION)

TABLE 3        ASIA-PACIFIC DRUG DISCOVERY MARKET, BY DRUG TYPE, 2019-2028 ($ MILLION)

TABLE 4        ASIA-PACIFIC DRUG DISCOVERY MARKET, BY SERVICE, 2019-2028 ($ MILLION)

TABLE 5        ASIA-PACIFIC DRUG DISCOVERY MARKET, BY END-USER, 2019-2028 ($ MILLION)

TABLE 6        ASIA-PACIFIC DRUG DISCOVERY MARKET, BY COUNTRY, 2019-2028 ($ MILLION)

List of Figures

FIGURE 1      ASIA-PACIFIC DRUG DISCOVERY MARKET, BY REGION, 2019-2028 ($ MILLION)

FIGURE 2      ASIA-PACIFIC DRUG DISCOVERY MARKET, BY SMALL MOLECULE DRUG, 2019-2028 ($ MILLION)

FIGURE 3      ASIA-PACIFIC DRUG DISCOVERY MARKET, BY BIOLOGIC DRUG, 2019-2028 ($ MILLION)

FIGURE 4      ASIA-PACIFIC DRUG DISCOVERY MARKET, BY HIGH THROUGHPUT SCREENING, 2019-2028 ($ MILLION)

FIGURE 5      ASIA-PACIFIC DRUG DISCOVERY MARKET, BY BIOCHIPS, 2019-2028 ($ MILLION)

FIGURE 6      ASIA-PACIFIC DRUG DISCOVERY MARKET, BY BIOINFORMATICS, 2019-2028 ($ MILLION)

FIGURE 7      ASIA-PACIFIC DRUG DISCOVERY MARKET, BY PHARMACOGENOMICS AND PHARMACOGENETICS, 2019-2028 ($ MILLION)

FIGURE 8      ASIA-PACIFIC DRUG DISCOVERY MARKET, BY COMBINATORIAL CHEMISTRY, 2019-2028 ($ MILLION)

FIGURE 9      ASIA-PACIFIC DRUG DISCOVERY MARKET, BY NANOTECHNOLOGY, 2019-2028 ($ MILLION)

FIGURE 10   ASIA-PACIFIC DRUG DISCOVERY MARKET, BY SPECTROSCOPY, 2019-2028 ($ MILLION)

FIGURE 11   ASIA-PACIFIC DRUG DISCOVERY MARKET, BY METABOLOMICS, 2019-2028 ($ MILLION)

FIGURE 12   ASIA-PACIFIC DRUG DISCOVERY MARKET, BY OTHER TECHNOLOGIES, 2019-2028 ($ MILLION)

FIGURE 13   ASIA-PACIFIC DRUG DISCOVERY MARKET, BY DRUG METABOLISM AND PHARMACOKINETICS (DMPK) SERVICES, 2019-2028 ($ MILLION)

FIGURE 14   ASIA-PACIFIC DRUG DISCOVERY MARKET, BY CHEMICAL SERVICES, 2019-2028 ($ MILLION)

FIGURE 15   ASIA-PACIFIC DRUG DISCOVERY MARKET, BY BIOLOGICAL SERVICES, 2019-2028 ($ MILLION)

FIGURE 16   ASIA-PACIFIC DRUG DISCOVERY MARKET, BY OTHER PHARMACEUTICAL SERVICES, 2019-2028 ($ MILLION)

FIGURE 17   ASIA-PACIFIC DRUG DISCOVERY MARKET, BY RESEARCH INSTITUTES, 2019-2028 ($ MILLION)

FIGURE 18   ASIA-PACIFIC DRUG DISCOVERY MARKET, BY PHARMACEUTICAL COMPANIES, 2019-2028 ($ MILLION)

FIGURE 19   ASIA-PACIFIC DRUG DISCOVERY MARKET, BY CONTRACT RESEARCH ORGANIZATIONS (CROS), 2019-2028 ($ MILLION)

FIGURE 20   ASIA-PACIFIC DRUG DISCOVERY MARKET, BY OTHER END-USERS, 2019-2028 ($ MILLION)

FIGURE 21   CHINA DRUG DISCOVERY MARKET 2019-2028 ($ MILLION)

FIGURE 22   INDIA DRUG DISCOVERY MARKET 2019-2028 ($ MILLION)

FIGURE 23   JAPAN DRUG DISCOVERY MARKET 2019-2028 ($ MILLION)

FIGURE 24   SOUTH KOREA DRUG DISCOVERY MARKET 2019-2028 ($ MILLION)

FIGURE 25   AUSTRALIA & NEW ZEALAND DRUG DISCOVERY MARKET 2019-2028 ($ MILLION)

FIGURE 26   ASEAN COUNTRIES DRUG DISCOVERY MARKET 2019-2028 ($ MILLION)

FIGURE 27   REST OF ASIA-PACIFIC DRUG DISCOVERY MARKET 2019-2028 ($ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$1,500.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$2,200.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;